2nd Edition of Diabetes and Endocrinology World Conference 2026

Abstract

Diabetes mellitus is increasingly recognized not only as a metabolic disorder but also as a disease of impaired cellular communication involving pancreatic islets, immune synapses, vascular endothelium, and insulin-responsive tissues. Early-stage cell interactions—including first contact, adhesion, receptor binding, and membrane signaling—are strongly influenced by biomechanical and bioenergetic states. Coherent light technologies such as optical tweezers, photobiomodulation, interferometric microscopy, and optical stretching offer unique opportunities to both quantify and modulate these processes. This review summarizes the physical principles governing light–cell interactions, evaluates their relevance to diabetic pathology, and discusses translational opportunities for precision photomedicine. Particular attention is given to beta-cell cohesion, autoimmune recognition, insulin receptor kinetics, and endothelial glycocalyx dysfunction. The convergence of biophotonics, mechanobiology, and artificial intelligence may enable a new class of non-pharmacological interventions for diabetes.

The expanded theoretical framework — incorporating the Maxwell stress tensor, Bell–Evans adhesion kinetics, PBM quantum yield models, and interferometric phase analysis — provides a rigorous physical foundation for understanding and manipulating first-stage cell interactions in diabetes. The specific laser parameters tabulated above offer actionable, experimentally validated guidelines for translating coherent light treatment from bench to bedside.